Meet us at these trade fairs
Upcoming trade shows!
From September 8 to 10, 2024, Devea will be present in Biarritz at the A3P conference.
From September 19 to 20, 2024, Devea will be present in Sousse, Tunisia, at the A3P trade show.
From September 11 to 13, 2024, Devea will be present at the GV-Solas conference in Würzburg, Germany.
Devea at AFI Remini on June 5 and 7, 2024
From June 5 to 7, 2024, Devea will be present at the AFI show in Remini, Italy. We’ll be there to discuss research, innovation and bio-decontamination together.
Are you in the pharmaceutical industry in Italy? Would you like to find out more about how to achieve safe, reliable disinfection with easy-to-use, energy-efficient equipment? Come and visit us at AFI in Rimini! Xavier will be happy to show you our technology, together with our partner Analytical Control De Mori s.r.l. – Gruppo A De Mori S.p.A.
Devea at AFSTAL Lille June 12-14, 2024
From June 12 to 14, 2024, Devea will be present in Lille for the AFSTAL trade show at stand n°1. We’ll be there to discuss research and developments in the pharmaceutical sector.
Devea at A3P Strasbourg on June 26 and 27, 2024
🔬 Join us for a show dedicated to best practices in analytical microbiology in the pharmaceutical and cosmetics industries. 🔬
📅 See you on June 26 and 27, 2024 at the Palais de la Musique et des Congrès in Strasbourg, where our team will be delighted to welcome you.
💡 This show is a great opportunity to exchange ideas on bio-decontamination processes. We can provide you with our expertise to ensure safe and efficient DSVA processes. Our commitment to your projects is our priority: risk assessment, consideration of your technical constraints, typology of areas to be controlled, customized methodology, equipment installation, IQ, OQ, PQ, training, consulting, after-sales services… We put our expertise at your service to guarantee the success of your biodecontamination processes.
🚀 Come and meet us to discuss your needs in detail and find out how we can help you set up effective biodecontamination processes tailored to your requirements.
🌟 Don’t miss this opportunity to benefit from personalized support and discover the latest innovations in sterilization and decontamination in the pharmaceutical industry!
Korean pharmaceutical industry with Devea on April 24, 2024.
You have heard through the grapevine about Devea, and want to see the devices working? Our Phileas technology are at hashtagICPI Week this week at the exhibition with Pierre Guhel and Henry Lee from our local partner Genesys! Let’s discussed your project, and tell you about our recent projects in the region!
Devea in Korea with Genesys
🚀 meanwhile, in Korea… our new team member Pierre Guhel has met with most of our Asian partners just before the New Year’s break, to introduce himself and hear about each country’s disinfection potential and challenges. Here with our Korean partner Genesys!
💡Pierre “generally speaking, distributors have been grateful for Devea’s support and reactivity until today, despite the distance. Now that they know I am here locally, they have expressed their enthusiasm regarding a closer relationship in the future: what a great way for me to start, and to onboard the different partners!! 🚀
Devea at A3P Milan on 23 April 2024
🔬 Join us for a day dedicated to best practice in sterilisation and decontamination processes in the pharmaceutical industry! 🔬
📅 See you on 23 April 2024 at the Enterprise Hotel in Milan, where our team will be delighted to welcome you.
💡 This day will be a privileged opportunity to discuss safe and effective bio-decontamination processes through airborne surface disinfection. We are committed to supporting you at every stage of your project: risk assessment, consideration of your technical constraints, typology of areas to be controlled, bespoke methodology, equipment installation, IQ, OQ, PQ, training, advice, after-sales service…. We put our expertise at your service to guarantee the success of your bio-decontamination processes.
🚀 Come and meet us to discuss your needs in detail and find out how we can help you set up effective bio-decontamination processes tailored to your requirements.
🌟 Don’t miss this opportunity to benefit from personalised support and discover the latest innovations in sterilisation and decontamination in the pharmaceutical industry!
Devea at A3P Strasbourg on 3 and 4 April 2024.
At the same time, the A3P Association is in Strasbourg, also today and tomorrow, to discuss the validation of bio-cleaning. Pierre Uminski will tell you how Devea solutions can help you comply with the new GMP Annex 1!
Devea at Polepharma on 3 and 4 April 2024 in Massy.
📣 The France Bioproduction Congress opened its doors this morning in Massy, France 📣Organised by POLEPHARMA, this congress is a unique opportunity for all biotech companies to meet and exchange ideas! Meet Virginie Haussmann, who will be answering your questions on how and why DSVA in bio-production can be your best ally: safety, efficacy, reproducibility, etc.
Devea at Contamin@Lyon on 27 and 28 March 2024.
DSVA workshop at Contamin@Lyon hosted by Devea on 28/03 at 2.45pm:
the challenges, key points for success, security, data traceability, etc. Thank you toASPEC for inviting devea-environnement to share our expertise and the best practices of the DSVA!
What questions are you asking yourself, what are the points for improvement in your DSVA? Let’s talk about it on the 28th in Lyon!
Devea at Maghreb Pharma from 5 to 7 February 2024 in Algiers.
The pharmaceutical industry in the Maghreb meets in Algiers next week, and Devea will be there! Join Xavier Blanc and our local partner BIOTECHNICA DWC-LLC around the legendary Phileas 75 for the latest Devea news and applications!
Algiers from 5 to 7 February 2024, stand A01
Devea at l’A3P Barcelone on Nov 28th 2023
🦠 Qualification of biodecontamination in a sterile production unit – feedback. 🦠
Chloé DESAINTMARTIN this morning shared her PQ experience at A3P Association in Barcelone.
🏢Qualifying Devea equipment, Phileas 75 and 250 in a grade A & B filling room, with 6-log BIs. —> Take home messages?
✅ Centrifugation is a robust technology, in large ranges of humidity (winters are dry)
✅ Qualifications are smooth, 1 line is qualified, 2 others in progress, 1 future line under works
✅ Low concentrated biocide is safe for users and cleanroom materials
✅ 21 CFR compliant reports and traceability
These qualification projects, like cycle developments, are what make our job interesting: supporting our clients with technical challenges, all the way through validation and compliance, for smooth everyday operations 😍
You missed the conference and want to know more? Contact us or leave a comment here!
Devea at CPHI Barcelona on 24 and 26 October 2023.
👏 Devea solutions are perfectly suited to the pharmaceutical industry: efficiency, safety, reliability, traceability. ✔️
📅 We will be present at the CPHI in Barcelona, from 24 to 26 October, stand H3T83.
Come and see a demonstration of the Phileas® ultra-fine, non-wetting fog, the MyPhileas traceability tool and the remote control!
We will be presenting our new Phileas® Control2, a new aerial surface disinfection device specially designed for pharmaceutical users!
🤝 Would you like to distribute our technology? Do not hesitate to contact us to make an appointment with us during the show!
Devea at A3P Biarritz from 10 to 12 October 2023.
✨ J-1 A3P Biarritz – new from DSVA ✨
🔬 Breaking news! 🗓️ From 10 to 12 October, the Devea team will be present in Biarritz at theA3P Association ‘s annual conference at stand n°R22. Come and talk to our experts in DSVA bio-decontamination, and find out what’s new with Devea this year!
At Devea, we are constantly looking for innovation to ensure a safer controlled environment. This year, we have something special to unveil at the event. 🚀
✨Join us at A3P Biarritz to be among the first to discover our new equipment in the field of bio-decontamination. The result of your feedback, industry developments and new requirements, don’t miss this preview launch and be the first to discover the new possibilities offered by this equipment! 🤫🔍
Devea at SFM Rennes from 4 to 6 October 2023.
🔬 D- 7: Devea at the SFM congress in Rennes! 🔬
We are delighted to announce our participation in the Société Française de Microbiologie (SFM) congress to be held in Rennes from 4 to 6 October. Join us at Stand n°42 to explore the fascinating world of microbiology!
🧫 On the programme: applications of Phileas® in different laboratory configurations, a demonstration of our Phileas® centrifugation technology and fascinating discussions on bioburden management and bio-decontamination. Find out how our bespoke solutions can meet your microbiological challenges.
🔍 Stay at the cutting edge of microbiology science and come and talk to our team of experts. We look forward to meeting you!
Devea at A3P Tours on 14 and 15 June 2023.
🦠 Microbial load control: Dive into the world of Barrier Technologies! 🧫
Last week’s A3P Tours was an opportunity to highlight the importance of combining DSVA with Barrier Technologies such as RABS and isolators.
Revolutionizing surface disinfection in the pharmaceutical industry.
Airborne surface disinfection (DSVA) has become an essential approach to ensuring the cleanliness and safety of production environments in the pharmaceutical industry.
At the A3P show in Tours, experts highlighted the importance of combining DSVA with barrier technologies such as RABS (Restricted Access Barrier Systems) and isolators. This synergy makes it possible to push back the limits of disinfection and maintain sterile, safe environments for the manufacture of vital medicines.
Reducing risks with DSVA.
Automatic DSVA works by diffusing disinfecting agents in mist form, covering all surfaces evenly. This method offers a number of advantages over traditional manual surface disinfection techniques. Firstly, it enables you to reach hard-to-reach areas and treat large surfaces in a short space of time.
What’s more, automatic DSVA eliminates the need to physically handle surfaces, reducing the risk of cross-contamination. Using appropriate disinfectants, DSVA can effectively eliminate bacteria, viruses, fungi and spores, creating a highly secure production environment.
Barrier technologies: a necessity to ensure safety for all.
However, to optimize the effectiveness of DSVA, it is essential to combine this approach with the appropriate barrier technologies. RABS are restricted access barrier systems that prevent contamination of the production environment by limiting operator access and creating a physical separation between the operator and the production area. The integration of RABS with DSVA ensures that disinfecting agents are confined within the production area, minimizing the risk of dispersal and external contamination. RABS also offer enhanced protection for operators, reducing their exposure to potentially dangerous pathogens.
Similarly, isolators play a crucial role in protecting sensitive operations and preventing cross-contamination. Isolators are hermetically sealed systems that enable hazardous substances to be handled in a controlled, confined environment. When combined with DSVA, isolators provide a double barrier of protection. The disinfecting agents released by the DSVA specifically target the surfaces inside the isolator, eliminating potentially present micro-organisms. This approach guarantees precise, targeted disinfection of critical areas, such as pharmaceutical product handling areas or package opening zones.
DSVA: an important role in workplace safety.
Several concrete examples illustrate the effectiveness of integrating DSVA with barrier technologies. In the production of anti-cancer drugs, where the handling of potentially hazardous products is necessary, the combined use of DSVA, isolators and RABS helps to maintain optimal conditions of biocharge control while ensuring the safety of operators.
Similarly, in the manufacture of sensitive biological agents, DSVA combined with isolators eliminates the risk of contamination during delicate operations.
Barrier technologies and DSVA: an effective combination.
In conclusion, the use of DSVA in combination with barrier technologies such as RABS and isolators is revolutionizing surface disinfection in the pharmaceutical industry. This approach makes it possible to maintain highly sterile production environments, improve operator safety and prevent cross-contamination. A3P Tours has played a key role in highlighting these scientific advances and promoting their adoption in the industry.
Thanks to this synergistic combination, the pharmaceutical industry can continue to provide safe, high-quality medicines to meet society’s healthcare needs.
☛ Please do not hesitate to contact us to find out more about our services :
Devea à l’A3P Liège le 8 juin 2023.
Le secteur pharmaceutique est dynamique en Belgique, comme l’atteste cette journée A3P Association à Liège aujourd’hui : des intervenants de qualité pour ce « back to basis » sur la hashtagdataintegrity, hashtagriskanalysis, hashtagquality – des sujets qui nous parlent chez Devea !
Avec notre partenaire Led Techno | Lab Solutions nous apportons des solutions novatrices de biodecontamination
Join us today at A3P Association in Château de Colonster (Liège – Belgium). Showing the benefits of the technology of airborne disinfection by Devea at the conference ‘a new eye, a review of fundamental concepts with a current look’.
Devea at Santexpo on Wednesday 24 May 2023 in Paris.
Dear fellow medical field partners, if you happen to be at SantExpo in Paris next week, please be sure to stop by the Village ASPEC and ask for a demo of how Airborne Surface Disinfection can help in the hospital: operation theater, pharmacy isolators, sensitive patient areas… we have solutions to help!
